Insider Holders & Insider Ownership - DURECT CORP (DRRX)

List of insiders holdings for DURECT CORP:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
# Insider Holder Name Report
Date Time		 Shares Owned
Directly
Indirectly		 Total
Shares Owned		 Filing
1 First Eagle Investment Management LLC
First Eagle Holdings Inc.
10% Owner		 2019-09-04 17:50:09 0
26,476,546		 26,476,546 Form 4
2 SCHRECK THOMAS A
Chief Financial Officer		 2005-02-17 20:14:14 3,022,450
0		 3,022,450 Form 13G
3 JIAN LI
InterimPrincipalAccountingOfcr		 2022-03-25 19:33:26 1,220,782
0		 1,220,782 Form 3
4 Arenberg Michael
Chief Financial Officer		 2022-01-10 17:49:05 546,350
0		 546,350 Form 4
5 NELSON TIMOTHY S
Sr. VP Business & Development		 2004-12-21 20:47:05 429,325
25,000		 454,325 Form 4
6 BROWN JAMES E
President & CEO		 2024-10-16 16:42:29 375,000
0		 375,000 Form 4
7 THEEUWES FELIX
Chairman and CSO		 2018-01-30 18:36:44 279,428
0		 279,428 Form 4
8 HOGAN MATTHEW J
Chief Financial Officer		 2018-01-30 18:37:49 278,910
0		 278,910 Form 4
9 YUM SU IL
Exec. VP Pharm./R&D		 2015-01-13 18:17:11 221,024
0		 221,024 Form 4
10 LIU JEAN I
Chief Legal Officer		 2011-07-13 19:25:05 184,627
0		 184,627 Form 4
11 Mendenhall Paula V
Exec. VP of Operations/Admin.		 2012-02-07 18:58:15 156,810
0		 156,810 Form 4
12 Stauffer Joseph William
CMO and Exec.VP Corp. Strategy		 2011-01-21 18:51:52 125,000
0		 125,000 Form 4
13 Papp Timothy M.
Chief Financial Officer		 2024-10-16 16:46:24 110,000
0		 110,000 Form 4
14 BENITO SIMON X
Director		 2021-12-09 13:35:14 105,000
0		 105,000 Form 4
15 Sussman Norman
Chief Medical Officer		 2024-10-16 16:47:15 104,000
0		 104,000 Form 4
16 GILLIS EDWARD M
VP Engineering		 2004-03-02 18:31:35 100,000
0		 100,000 Form 4
17 Miksztal Andrew
VP Pharmaceutical R&D		 2006-01-10 21:48:29 75,000
0		 75,000 Form 4
18 HALLADAY STEVEN
VP Clinical and Regulatory		 2006-01-10 20:59:15 72,000
0		 72,000 Form 4
19 LANGECKER PETER
Chief Medical Officer		 2009-05-26 14:58:06 66,000
0		 66,000 Form 4
20 Neukermans Armand
Director		 2020-06-18 21:37:41 55,000
0		 55,000 Form 4
21 SAXE JON S
Director		 2020-06-18 21:38:29 55,000
0		 55,000 Form 4
22 HOFFMANN DAVE
Director		 2022-06-17 16:10:42 55,000
0		 55,000 Form 4
23 CHAN TAI WAH
VP Pharma. Research & Develp.		 2005-11-08 21:14:57 51,371
1000		 52,371 Form 4
24 TIPTON ARTHUR J
Sr.VP Bioerodible Product Dev.		 2004-03-02 18:35:41 50,000
0		 50,000 Form 4
25 Joice Judy R
Sr. VP Operations & Corp QA		 2023-02-23 13:20:34 37,456
0		 37,456 Form 4
26 Shepard Jay
Director		 2016-06-23 18:39:46 35,000
0		 35,000 Form 4
27 CASEY MICHAEL D
Director		 2013-06-26 18:47:19 35,000
0		 35,000 Form 4
28 TAYLOR MICHAEL J
VP, Non Clinical Research		 2004-04-02 20:51:10 29,388
0		 29,388 Form 4/A
29 AZAB MOHAMMAD
Director		 2024-09-27 16:16:26 5,500
0		 5,500 Form 4
30 Blaschke Terrence F
Director		 2024-09-27 16:16:52 5,500
0		 5,500 Form 4
31 Farfel Gail M
Director		 2024-09-27 16:17:16 5,500
0		 5,500 Form 4
32 GARCIA PETER S
Director		 2024-09-27 16:17:48 5,500
0		 5,500 Form 4
33 Maderis Gail J
Director		 2024-09-27 16:18:21 5,500
0		 5,500 Form 4
34 Robertson Judith J.
Director		 2024-09-27 16:18:55 5,500
0		 5,500 Form 4
35 Bleichroeder LP
10% Owner		 2023-12-01 16:28:30 0
0		 0 Form 13G
36 First Eagle Investment Management LLC
21 APRIL FUND L.P.
21 APRIL FUND LTD.
First Eagle Value in Biotechnology Master Fund Ltd.
First Eagle Holdings Inc.
10% Owner		 2019-09-04 17:27:47 0
0		 0 Form 13G